 | | | | China said on Monday it will tighten regulations on human genetic material, putting checks on the passing of it abroad and insisting that any foreign companies or institutes wanting to use it in their work do so with a Chinese partner. | | |
| | | (Reuters Health) - In people at high risk for type 1 diabetes, 14 days of therapy with the experimental drug teplizumab delayed development of the disease by a year or more, according to results from a mid-stage study presented Sunday. | | |
| | | Insulin-dependent patients with type 2 diabetes saw a significant drop in their blood sugar levels after wearing Abbott Laboratories Inc's continuous glucose monitoring system for three months compared with those who use routine fingerstick testing, researchers said on Saturday. | | |
| | | The U.S. Department of Agriculture has confirmed the discovery of unapproved, genetically modified (GM) wheat plants growing in an un-planted agricultural field in Washington state. | | |
| | | A federal judge on Friday tossed the convictions of a co-owner and former employee of a Massachusetts compounding pharmacy accused of conspiring to help it evade regulatory oversight before its drugs caused a deadly 2012 fungal meningitis outbreak. | | |
| | | The Joe Biden Express to the 2020 Democratic presidential nomination went a bit off track this week. | | |
| | | (Reuters Health) - People with inflammatory bowel disease - either Crohn's disease or ulcerative colitis - may incur health costs more than three times higher than individuals without these conditions, a U.S. study suggests. | | |
| | | (Reuters Health) - With increased access to insurance under the Affordable Care Act (ACA), known as Obamacare, fewer middle-aged people are dying from heart disease, a U.S. study suggests. | | |
| | | (Reuters Health) - If you're talking vitamin D and expecting it to lower your risk of getting type 2 diabetes when you get older, it's time to lower your expectations. | | |
| | | (Reuters Health) - Fewer and fewer psychiatrists are accepting Medicaid even as increasing numbers of patients have gained mental health coverage through expansion of the program, a new study suggests. | | |
| | | The U.S. Food and Drug Administration and the Federal Trade Commission on Friday issued warning letters to four flavored e-liquid product makers, stepping up pressure on firms using social media influencers to promote their products. | | |
|
| |
